The Alzheimer’s Foundation of America (AFA) has awarded $518,391 in research grant funding to the Broad Institute and One Mind to study the role of the brain’s immune cells in the onset and progression of Alzheimer’s disease (AD). The hope is that, with more understanding of immune cells and brain inflammatory processes, scientists can learn more about how Alzheimer’s works. In turn, that could lead to new and better treatments for the neurodegenerative disease. Researchers…
You must be logged in to read/download the full post.
The post AFA Awards $518K for Study of Neuroimmune Interactions in AD Onset, Progression appeared first on BioNewsFeeds.